Meridigen’s first high-standard pharmaceutical plant is entirely constructed and operated based on the international standard PIC/S GMP. It manufactures stem cell drugs for clinical use with strict quality control processes from the origin of raw materials to the facilities. At the same time, we strictly control every step of manufacturing processes to avoid contamination or mislabelling. Validations are also demanded under quality risk management system via both software and hardware. These ensure a steady supply of our drugs. We aim at being the first stem cell drug plant passed PIC/S GMP, and providing patients with the highest quality and safest stem-cell based products.